AlphAIAlphAI — Financial news for AI agents
StockOTC · US · USDHealthcare · Biotechnology

$NWBO

NORTHWEST BIOTHERAPEUTICS INC

Price · $NWBOvia TradingView
AI sentiment · 7d2 articles
OCT 2net (bullish − bearish)OCT 8
Bullish
1
Neutral
1
Bearish
0
Insider · 30dAll trades →

No SEC Form 4 filings for $NWBO in the last 30 days.

See all $NWBO insider activity →
Top stories · $NWBOMore →
OCT 8·prnewswire.comLow

Northwest Biotherapeutics and the UK National Health Service Blood and Transplant Announce Collaboration to Support DCVax®-L Production

Northwest Biotherapeutics (NWBO) and the UK National Health Service Blood and Transplant (NHSBT) have partnered to support the production of the experimental cancer vaccine DCVax®-L. NHSBT will use its therapeutic apheresis and cell processing capabilities to aid in the manufacturing process. The collaboration initially involves Leeds and Oxford, with plans to expand across England.

JUL 31·SEC EDGAR 8-K

NORTHWEST BIOTHERAPEUTICS INC (NWBO): Entry into a Material Definitive Agreement

NORTHWEST BIOTHERAPEUTICS INC (NWBO) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry Into A Material Definitive Agreement. On July 29, 2026, Northwest Biotherapeutics (OTCQB:NWBO) (the “Company” or “NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, entered into a $4.9 million convertible Pr

NWBO sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 2 news stories mentioning NWBO (NORTHWEST BIOTHERAPEUTICS INC). Coverage has skewed bullish: 1 bullish, 1 neutral, and 0 bearish.

Recent NWBO coverage spans financial news and corporate actions.

What's driving NWBO

  • The partnership could enhance manufacturing capacity and accelerate UK market entry, supporting the stock.

    prnewswire.com · Oct 8, 2026

  • The financing adds near-term liquidity but introduces dilution and conversion overhang risk, likely pressuring sentiment until terms are digested.

    SEC EDGAR 8-K · Jul 31, 2026

AlphAI scores every news story that mentions NWBO with an AI model for sentiment and relevance, and aggregates insider trades from NORTHWEST BIOTHERAPEUTICS INC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $NWBO

Score
OCT 8$NWBOLowprnewswire.com

Northwest Biotherapeutics and the UK National Health Service Blood and Transplant Announce Collaboration to Support DCVax®-L Production

Northwest Biotherapeutics (NWBO) and the UK National Health Service Blood and Transplant (NHSBT) have partnered to support the production of the experimental cancer vaccine DCVax®-L. NHSBT will use its therapeutic apheresis and cell processing capabilities to aid in the manufacturing process. The collaboration initially involves Leeds and Oxford, with plans to expand across England.

2 min read
JUL 31$NWBOMedSEC EDGAR 8-K

NORTHWEST BIOTHERAPEUTICS INC (NWBO): Entry into a Material Definitive Agreement

NORTHWEST BIOTHERAPEUTICS INC (NWBO) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry Into A Material Definitive Agreement. On July 29, 2026, Northwest Biotherapeutics (OTCQB:NWBO) (the “Company” or “NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, entered into a $4.9 million convertible Pr

4 min read

Related tickers

More in Biotechnology